🇺🇸 FDA
Patent

US 11964960

Pyridinone- and pyridazinone-based compounds and uses thereof

granted A61PA61P1/16A61P11/00

Quick answer

US patent 11964960 (Pyridinone- and pyridazinone-based compounds and uses thereof) held by Tri-Institutional Therapeutics Discovery Institute, Inc. expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Tri-Institutional Therapeutics Discovery Institute, Inc.
Grant date
Tue Apr 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P1/16, A61P11/00, A61P13/12, A61P17/00